Focus Partners Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3M Sell
52,563
-19,489
-27% -$7.23M 0.02% 510
2026
Q1
$21.8M Buy
72,052
+17,111
+31% +$5.62M 0.02% 479
2025
Q4
$19.3M Buy
54,941
+18,223
+50% +$6.16M 0.02% 499
2025
Q3
$7.54M Buy
36,718
+14,279
+64% +$4.44M 0.01% 639
2025
Q2
$8.73M Sell
22,439
-7
-0% -$2.82K 0.02% 528
2025
Q1
$9.76M Buy
22,446
+976
+5% +$392K 0.02% 480
2024
Q4
$7.92M Sell
21,470
-955
-4% -$400K 0.02% 513
2024
Q3
$11.7M Buy
22,425
+2,356
+12% +$1.26M 0.04% 376
2024
Q2
$10.9M Buy
20,069
+1,243
+7% +$657K 0.04% 370
2024
Q1
$9.76M Buy
18,826
+1,737
+10% +$864K 0.08% 218
2023
Q4
$8.06M Buy
+17,089
New +$7.9M 0.11% 175

Other funds holding ELV

Focus Partners Wealth's ELV Position: Q2 2026 in Review

Focus Partners Wealth reduced its Elevance Health (ELV) stake by 27% in Q2 2026, selling an estimated $7.23M and leaving 52,563 shares worth $20.3M. The position accounts for 0.02% of the portfolio, ranked #510.

Focus Partners Wealth first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.8M in Q1 2026. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Focus Partners Wealth held 52,563 shares of Elevance Health worth $20.3M as of Q2 2026.
  • Focus Partners Wealth sold 19,489 Elevance Health shares in Q2 2026, an estimated $7.23M.
  • Elevance Health made up 0.02% of Focus Partners Wealth's portfolio in Q2 2026, its #510 holding.
  • Focus Partners Wealth first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Elevance Health position peaked at $21.8M in Q1 2026.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.